Phase 2 Readout
MIRM: Phase 2 Readout: volixibat
December 31, 2026 · volixibat. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Mirum Pharmaceuticals, Inc. (MIRM)
- Drug
- volixibat
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: volixibat
- Drug
- volixibat
- Indication
- cholestatic pruritus in patients with primary sclerosing cholangitis (PSC)